IMR Press / CEOG / Volume 7 / Issue 2 / pii/1634266343319-784714636

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Serum prolactin levels during inhibition of lactation by cyclofenil
Show Less
1 Department of Obstetrics and Gynecology, University of Pavia
Clin. Exp. Obstet. Gynecol. 1980, 7(2), 131–134;
Published: 10 June 1980
Abstract

Inhibition of lactation is now usually achieved by the use of dopaminergic or antiserotoninergic drugs. An interesting, alternative approach, however, is represented by the use of antiestrogenic agents, though their mechanism of action is still uncertain. We have given cyclofenil at daily doses of 1200, 800 and 600 mg to a total of 100 post-partum women who required not to lactate. The clinical results were excellent or good in 83 women, fair in 9 and poor in 8. After 3, 5, and 7 days of treatment serum prolactin levels of treated women, if compared with those of control group, showed a decrease ranging from 25 to 27%, from 42 to 44%, and from 60 to 64% respectively. Blood coagulation, as judged by several laboratory parameters, did not show abnormal changes in any subject treated with cyclofenil.
Share
Back to top